| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |